Literature DB >> 18992892

Simultaneous analysis by capillary electrophoresis of five amyloid peptides as potential biomarkers of Alzheimer's disease.

Romain Verpillot1, Markus Otto, Hans Klafki, Myriam Taverna.   

Abstract

We report here a CE method for the separation and quantitation of five amyloid peptides (Abeta1-42, 1-40, 1-39, 1-38, and 1-37) considered as potential biomarkers of Alzheimer's disease. These amyloid peptides have very similar structures. Sample preparation and storage conditions are critical parameters to ensure their solubility and to avoid the aggregation process in particular for Abeta1-42. Their solubility was found fully dependent on the NH(4)OH concentration that was employed initially to dissolve the lyophilized amyloid peptides. Conditions to achieve a full separation of these peptides were found using a dynamic coating with 1,4-diaminobutane (DAB). The linear decrease of their electrophoretic mobility highlighted an ion-pairing phenomenon between the peptides and DAB. The optimal background electrolyte was a 40 mM borate buffer, pH 9 containing 3 mM of DAB. Under these conditions, resolutions ranged from 1.3 to 2.4 with theoretical plates reaching 300,000. Under the retained conditions, we showed that adsorption of peptides to silica was negligible (recovery over 94.5%) and depletion effect of the background electrolyte was overcome. The method was finally validated in terms of linearity and repeatability and the limits of detection for the five Abeta peptides were estimated. The inter-day repeatability of the migration times was very satisfactory with RSDs less than 1.55%. The RSDs of the peak areas were below 5%. With this CE-UV method, limits of detection of the peptides ranged from 300 to 500 nM. We finally demonstrated that this method can be applied to real biological samples such as CSF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992892     DOI: 10.1016/j.chroma.2008.10.051

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  4 in total

1.  Development of a magnetic immunosorbent for on-chip preconcentration of amyloid β isoforms: Representatives of Alzheimer's disease biomarkers.

Authors:  Zuzana Svobodova; Mohamad Reza Mohamadi; Barbora Jankovicova; Hermann Esselmann; Romain Verpillot; Markus Otto; Myriam Taverna; Jens Wiltfang; Jean-Louis Viovy; Zuzana Bilkova
Journal:  Biomicrofluidics       Date:  2012-05-24       Impact factor: 2.800

Review 2.  Unraveling the early events of amyloid-β protein (Aβ) aggregation: techniques for the determination of Aβ aggregate size.

Authors:  N Elizabeth Pryor; Melissa A Moss; Christa N Hestekin
Journal:  Int J Mol Sci       Date:  2012-03-07       Impact factor: 6.208

3.  Ultra-sensitive detection of protein biomarkers for diagnosis of Alzheimer's disease.

Authors:  Hei-Nga Chan; Di Xu; See-Lok Ho; Man Shing Wong; Hung-Wing Li
Journal:  Chem Sci       Date:  2017-03-24       Impact factor: 9.825

4.  Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane.

Authors:  Liang Zhang; Sergey Trushin; Trace A Christensen; Utkarsh Tripathi; Courtney Hong; Rachel E Geroux; Kyle G Howell; Joseph F Poduslo; Eugenia Trushina
Journal:  Neurobiol Dis       Date:  2018-03-02       Impact factor: 5.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.